These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 11981563

  • 1. An HGF-MSP chimera disassociates the trophic properties of scatter factors from their pro-invasive activity.
    Michieli P, Cavassa S, Basilico C, De Luca A, Mazzone M, Asti C, Chiusaroli R, Guglielmi M, Bossù P, Colotta F, Caselli G, Comoglio PM.
    Nat Biotechnol; 2002 May; 20(5):488-95. PubMed ID: 11981563
    [Abstract] [Full Text] [Related]

  • 2. A novel recombinant soluble splice variant of Met is a potent antagonist of the hepatocyte growth factor/scatter factor-Met pathway.
    Tiran Z, Oren A, Hermesh C, Rotman G, Levine Z, Amitai H, Handelsman T, Beiman M, Chen A, Landesman-Milo D, Dassa L, Peres Y, Koifman C, Glezer S, Vidal-Finkelstein R, Bahat K, Pergam T, Israel C, Horev J, Tsarfaty I, Ayalon-Soffer M.
    Clin Cancer Res; 2008 Jul 15; 14(14):4612-21. PubMed ID: 18628476
    [Abstract] [Full Text] [Related]

  • 3. Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells.
    Song L, Turkson J, Karras JG, Jove R, Haura EB.
    Oncogene; 2003 Jul 03; 22(27):4150-65. PubMed ID: 12833138
    [Abstract] [Full Text] [Related]

  • 4. Hepatocyte growth factor activator is a serum activator of single-chain precursor macrophage-stimulating protein.
    Kawaguchi M, Orikawa H, Baba T, Fukushima T, Kataoka H.
    FEBS J; 2009 Jul 03; 276(13):3481-90. PubMed ID: 19456860
    [Abstract] [Full Text] [Related]

  • 5. In vitro inhibition of matriptase prevents invasive growth of cell lines of prostate and colon carcinoma.
    Förbs D, Thiel S, Stella MC, Stürzebecher A, Schweinitz A, Steinmetzer T, Stürzebecher J, Uhland K.
    Int J Oncol; 2005 Oct 03; 27(4):1061-70. PubMed ID: 16142324
    [Abstract] [Full Text] [Related]

  • 6. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
    Yang J, Dai C, Liu Y.
    J Am Soc Nephrol; 2005 Jan 03; 16(1):68-78. PubMed ID: 15537870
    [Abstract] [Full Text] [Related]

  • 7. Proteolytic cleavage and activation of pro-macrophage-stimulating protein by resident peritoneal macrophage membrane proteases.
    Wang MH, Skeel A, Leonard EJ.
    J Clin Invest; 1996 Feb 01; 97(3):720-7. PubMed ID: 8609228
    [Abstract] [Full Text] [Related]

  • 8. Targeting TGF-beta1 increases hepatocyte growth factor (HGF/SF) levels in external auditory canal cholesteatoma (EACC) epithelial cell culture.
    Naim R, Chang RC, Alfano SS, Riedel F, Bayerl C, Sadick H, Bran G, Hormann K.
    Regul Pept; 2005 Aug 15; 130(1-2):75-80. PubMed ID: 15913806
    [Abstract] [Full Text] [Related]

  • 9. Hepatocyte growth factor; expression, concentration and biological activity in chronic leg ulcers.
    Nayeri F, Olsson H, Peterson C, Sundqvist T.
    J Dermatol Sci; 2005 Feb 15; 37(2):75-85. PubMed ID: 15659325
    [Abstract] [Full Text] [Related]

  • 10. Fully human monoclonal antibodies to hepatocyte growth factor with therapeutic potential against hepatocyte growth factor/c-Met-dependent human tumors.
    Burgess T, Coxon A, Meyer S, Sun J, Rex K, Tsuruda T, Chen Q, Ho SY, Li L, Kaufman S, McDorman K, Cattley RC, Sun J, Elliott G, Zhang K, Feng X, Jia XC, Green L, Radinsky R, Kendall R.
    Cancer Res; 2006 Feb 01; 66(3):1721-9. PubMed ID: 16452232
    [Abstract] [Full Text] [Related]

  • 11. Hepatocyte growth factor stimulates cell motility in cultures of the striatal progenitor cells ST14A.
    Cacci E, Salani M, Anastasi S, Perroteau I, Poiana G, Biagioni S, Augusti-Tocco G.
    J Neurosci Res; 2003 Dec 01; 74(5):760-8. PubMed ID: 14635227
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
    Qian F, Engst S, Yamaguchi K, Yu P, Won KA, Mock L, Lou T, Tan J, Li C, Tam D, Lougheed J, Yakes FM, Bentzien F, Xu W, Zaks T, Wooster R, Greshock J, Joly AH.
    Cancer Res; 2009 Oct 15; 69(20):8009-16. PubMed ID: 19808973
    [Abstract] [Full Text] [Related]

  • 13. Noncompetitive inhibition of hepatocyte growth factor-dependent Met signaling by a phage-derived peptide.
    Tam EM, Runyon ST, Santell L, Quan C, Yao X, Kirchhofer D, Skelton NJ, Lazarus RA.
    J Mol Biol; 2009 Jan 09; 385(1):79-90. PubMed ID: 18973760
    [Abstract] [Full Text] [Related]

  • 14. Transcriptional targets of hepatocyte growth factor signaling and Ki-ras oncogene activation in colorectal cancer.
    Seiden-Long IM, Brown KR, Shih W, Wigle DA, Radulovich N, Jurisica I, Tsao MS.
    Oncogene; 2006 Jan 05; 25(1):91-102. PubMed ID: 16158056
    [Abstract] [Full Text] [Related]

  • 15. HGF-MSP chimera protects kidneys from ischemia-reperfusion injury.
    Xue F, Isaka Y, Takahara T, Imamura R, Suzuki C, Ichimaru N, Michieli P, Takahara S.
    Biochem Biophys Res Commun; 2007 Nov 16; 363(2):451-6. PubMed ID: 17888399
    [Abstract] [Full Text] [Related]

  • 16. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
    Li Y, Lal B, Kwon S, Fan X, Saldanha U, Reznik TE, Kuchner EB, Eberhart C, Laterra J, Abounader R.
    Cancer Res; 2005 Oct 15; 65(20):9355-62. PubMed ID: 16230398
    [Abstract] [Full Text] [Related]

  • 17. Scatter Factors in renal disease: Dr. Jeckyll and Mr. Hyde?
    Rampino T, Gregorini M, Dal Canton A.
    Cytokine Growth Factor Rev; 2009 Feb 15; 20(1):77-85. PubMed ID: 19201250
    [Abstract] [Full Text] [Related]

  • 18. Molecular basis for the cell type specific induction of SnoN expression by hepatocyte growth factor.
    Tan R, Zhang X, Yang J, Li Y, Liu Y.
    J Am Soc Nephrol; 2007 Aug 15; 18(8):2340-9. PubMed ID: 17625116
    [Abstract] [Full Text] [Related]

  • 19. Hepatocyte growth factor ameliorates renal interstitial inflammation in rat remnant kidney by modulating tubular expression of macrophage chemoattractant protein-1 and RANTES.
    Gong R, Rifai A, Tolbert EM, Biswas P, Centracchio JN, Dworkin LD.
    J Am Soc Nephrol; 2004 Nov 15; 15(11):2868-81. PubMed ID: 15504940
    [Abstract] [Full Text] [Related]

  • 20. Adaptor molecule Crk is required for sustained phosphorylation of Grb2-associated binder 1 and hepatocyte growth factor-induced cell motility of human synovial sarcoma cell lines.
    Watanabe T, Tsuda M, Makino Y, Ichihara S, Sawa H, Minami A, Mochizuki N, Nagashima K, Tanaka S.
    Mol Cancer Res; 2006 Jul 15; 4(7):499-510. PubMed ID: 16849525
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.